Krupakar Subramaniam
Postgraduate AssociateDownloadHi-Res Photo
About
Copy Link
Titles
Postgraduate Associate
Appointments
Laboratory Medicine
Postgraduate AssociatePrimary
Other Departments & Organizations
- All Institutions
- Foxman Lab
- Laboratory Medicine
Education & Training
- BS
- Yale University (2025)
Research
Copy Link
Overview
Medical Research Interests
Asthma; Cell Biology; Epithelial Cells; Immunity, Innate; Immunity, Mucosal; Interferons; Respiratory Mucosa
ORCID
0009-0008-1750-5626
Research at a Glance
Yale Co-Authors
Frequent collaborators of Krupakar Subramaniam's published research.
Ellen F Foxman, MD, PhD
Michael Mak
Publications
2026
Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells.
Subramaniam KV, Lim HJ, Wang B, Mihaylova VT, Thompson EN, Krause DS, Foxman EF. Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells. PLoS Biol 2026, 24: e3003615. PMID: 41587178, DOI: 10.1371/journal.pbio.3003615.Peer-Reviewed Original Research
2024
Biophysical and biochemical aspects of immune cell–tumor microenvironment interactions
Benmelech S, Le T, McKay M, Nam J, Subramaniam K, Tellez D, Vlasak G, Mak M. Biophysical and biochemical aspects of immune cell–tumor microenvironment interactions. APL Bioengineering 2024, 8: 021502. PMID: 38572312, PMCID: PMC10990568, DOI: 10.1063/5.0195244.Peer-Reviewed Original ResearchCitationsAltmetricConceptsTumor microenvironmentImprove CAR T cell therapyCAR-T cell therapyCD4+ T cellsCancer cellsAdaptive immune systemDistribution of cancer cellsCD8+T cellsImmunosuppressive responsePro-tumorImmune cellsMicroenvironment interactionsCell therapyExtracellular matrixCancer progressionImmune systemTumorCells-thatSpatial distribution of cancer cellsCancerCellsCD8CD4Therapy
Academic Achievements & Community Involvement
Copy Link
Get In Touch
Copy Link